Horse News and Research

RSS

Inotuzumab ozogamicin selectively destroys malignant cells responsible for ALL in weekly dosing

A potent chemotherapy agent wrapped within a monoclonal antibody selectively destroys the malignant cells responsible for acute lymphocytic leukemia (ALL) in either weekly or monthly dosing, researchers report at the 54th ASH Annual Meeting and Exposition.

12 Dec 2012

Researchers examine impact of exercise on mare reproductive health and embryo transfer

In the latest issue of the Journal of Animal Science, researchers at Clemson University and the University of Florida examine the impact of exercise on mare reproductive health and embryo transfer.

6 Dec 2012

Study: Controversial treatment for autism spectrum disorder may be harmful

A controversial treatment for autism spectrum disorder (ASD) is not only ineffective but may be harmful, according to a study conducted by Baylor University researchers.

30 Nov 2012

ArmaGen closes $17M Series A financing

ArmaGen Technologies, Inc. today announced the closing of a $17 million Series A financing to support the development of brain-penetrating recombinant protein therapeutics.

29 Nov 2012

Two-route drug combination best for horse joint pain

A combination of systemic nonsteroidal anti-inflammatory drugs plus intrasynovial glucocorticosteroids is superior to either medication alone in improving outcomes for lame horses with perisynovial pain of the metacarpophalangeal joint, report Dutch researchers.

28 Nov 2012

Enrollment complete in Tryton's Pivotal IDE Side Branch Stent trial to treat bifurcation lesions

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the completion of enrollment in the TRYTON Pivotal IDE trial evaluating the Tryton Side Branch Stent.

26 Nov 2012

Nano-reinforced plastics improve friction resistance of orthodontics

Brackets made from clear plastic polymer used in dental correction orthodontics have produced very good results in recent years, especially in relation to the improved esthetics when compared to metal brackets, but they do present certain problems of wear and tear within the mouth.

29 Oct 2012

Vitamin-rich berries may help prevent glandular ulcers in horses

Adding sea buckthorn berries to the diet of horses could reduce the incidence of glandular gastric ulcers, report researchers.

24 Oct 2012

New discovery could help revolutionize antibiotic treatment of bacteria

Three Simon Fraser University scientists are among six researchers who've made a discovery that could help revolutionize antibiotic treatment of deadly bacteria.

20 Oct 2012

Vice Presidential candidates debate Medicare plan specifics

During last night's face off, Vice President Joe Biden and GOP vice presidential hopeful Paul Ryan offered different plans, visions and, sometimes, even numbers for Medicare's future.

13 Oct 2012

Healthy lungs can retain age-related cognitive functions

Keeping the lungs healthy could be an important way to retain thinking functions that relate to problem-solving and processing speed in one's later years, new research suggests.

9 Oct 2012

Synthetic hybrid molecules more effectively tackle chemo-resistant cancers

When Linda Tuttle was diagnosed with breast cancer, she never imagined her experience would inspire her colleagues to design new treatments to tackle the disease.

3 Oct 2012

Pancreatic B-cell dedifferentiation leads to decline in insulin production in type 2 diabetes

Scientists generally think that reduced insulin production by the pancreas, a hallmark of type 2 diabetes, is due to the death of the organ's beta cells. However, a new study by Columbia University Medical Center (CUMC) researchers shows that beta cells do not die but instead revert to a more fundamental, undifferentiated cell type.

15 Sep 2012

ARGO Medical, Cyclone Technologies announce availability of ReWalk exoskeleton system

5 Sep 2012

Exoskeleton technology now available to take home

Exoskeleton technology leader, ARGO Medical Technologies, along with mobility solutions provider, Cyclone Technologies, announced today that Claire Lomas has become the first person to take home an exoskeleton system for personal use. Claire demonstrated her personal ReWalk™ at the annual International Spinal Cord Society (ISCoS) meeting held at the Queen Elizabeth II Conference Center.

5 Sep 2012

UMass Medical, Serum Institute of India partner on anti-rabies monoclonal antibody pivotal trial

A pivotal clinical trial for an anti-rabies human monoclonal antibody (RMAb) being developed through a collaborative partnership between MassBiologics of the University of Massachusetts Medical School and the Serum Institute of India, Ltd., is starting to enroll patients.

8 Aug 2012

Allergies may reduce risk of brain cancer

New research adds to the growing body of evidence suggesting that there's a link between allergies and reduced risk of a serious type of cancer that starts in the brain. This study suggests the reduced risk is stronger among women than men, although men with certain allergy profiles also have a lower tumor risk.

3 Aug 2012

Viewpoints: 'The best thing George W. Bush did as president;' Finding less harmful health cuts; Navigating the future of Medicaid

This is a moment for all Americans to be proud of the best thing George W. Bush did as president: launching an initiative to combat AIDS in Africa that has saved millions of lives. All week, more than 20,000 delegates from around the world have been attending the 19th International AIDS Conference here in Washington. They look like any other group of conventioneers, laden with satchels and garlanded with name tags. But some of these men and women would be dead if not for Bush's foresight and compassion.

28 Jul 2012

Memory-binding process allows people to better understand new concepts and make decisions

When humans learn, their brains relate new information with past experiences to derive new knowledge, according to psychology research from The University of Texas at Austin.

12 Jul 2012

Interfascicular matrix essential for tendon function

Tendon disorders cost the UK economy more than -7bn a year and now scientists at Queen Mary, University of London have identified a vital component of tendons which could help treat them.

5 Jul 2012